These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 9066339

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Class III antiarrhythmic effects of zatebradine. Time-, state-, use-, and voltage-dependent block of hKv1.5 channels.
    Valenzuela C, Delpón E, Franqueza L, Gay P, Pérez O, Tamargo J, Snyders DJ.
    Circulation; 1996 Aug 01; 94(3):562-70. PubMed ID: 8759103
    [Abstract] [Full Text] [Related]

  • 5. Characterization of mibefradil block of the human heart delayed rectifier hKv1.5.
    Perchenet L, Clément-Chomienne O.
    J Pharmacol Exp Ther; 2000 Nov 01; 295(2):771-8. PubMed ID: 11046117
    [Abstract] [Full Text] [Related]

  • 6. Interaction of ropivacaine with cloned cardiac Kv4.3/KChIP2.2 complexes.
    Friederich P, Solth A.
    Anesthesiology; 2004 Dec 01; 101(6):1347-56. PubMed ID: 15564942
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of propafenone and 5-hydroxy-propafenone on hKv1.5 channels.
    Franqueza L, Valenzuela C, Delpón E, Longobardo M, Caballero R, Tamargo J.
    Br J Pharmacol; 1998 Nov 01; 125(5):969-78. PubMed ID: 9846634
    [Abstract] [Full Text] [Related]

  • 13. Modulation of a cloned human A-type voltage-gated potassium channel (hKv1.4) by the protein tyrosine kinase inhibitor genistein.
    Zhang ZH, Wang Q.
    Pflugers Arch; 2000 Sep 01; 440(5):784-92. PubMed ID: 11007322
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of rupatadine, a new dual antagonist of histamine and platelet-activating factor receptors, on human cardiac kv1.5 channels.
    Caballero R, Valenzuela C, Longobardo M, Tamargo J, Delpón E.
    Br J Pharmacol; 1999 Nov 01; 128(5):1071-81. PubMed ID: 10556945
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Torilin from Torilis japonica (Houtt.) DC. blocks hKv1.5 channel current.
    Kwak YG, Kim DK, Ma TZ, Park SA, Park H, Jung YH, Yoo DJ, Eun JS.
    Arch Pharm Res; 2006 Oct 01; 29(10):834-9. PubMed ID: 17121176
    [Abstract] [Full Text] [Related]

  • 20. Amide local anesthetics potently inhibit the human tandem pore domain background K+ channel TASK-2 (KCNK5).
    Kindler CH, Paul M, Zou H, Liu C, Winegar BD, Gray AT, Yost CS.
    J Pharmacol Exp Ther; 2003 Jul 01; 306(1):84-92. PubMed ID: 12660311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.